Thank you, Madam Chair.
Dr. Nguyen, you mentioned the disastrous economic consequences of inaction on antimicrobial resistance. However, Canada is the only G7 country that invested less in research and development over a sustained 20-year period in proportion to its GDP.
In your opinion, could the failure to make bold investments in prevention, which is one of the five pillars of the One Health project, cost significantly more in the long run?